Advancing Cancer Immunotherapy through Innovative Approaches
NewsRamp Business Startups Headlines and Breaking News
NewsRamp Business Startups Podcast · NewsRamp
December 23, 20252m 4s
Audio is streamed directly from the publisher (cdn.newsramp.app) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Valora Therapeutics is exploring a new approach to increase response rates for cancer immunotherapy by developing AbLecs and moving towards clinical trials. This startup, alongside companies like Calidi Biotherapeutics Inc., aims to address the limited success of immunotherapy in treating cancer patients. For more insights on biotechnology and biomedical sciences, visit BioMedWire.com.